• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    Anacor Pharmaceuticals, Inc. (ANAC)

    -NGM
    30.58 Up 0.16(0.53%) Dec 24, 1:00PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Net Income (31,342) (24,508) (21,172) 130,748  
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation644  648  660  388  
    Adjustments To Net Income3,742  3,191  4,736  1,430  
    Changes In Accounts Receivables(1,156)1,821  (1,353)437  
    Changes In Liabilities42,079  1,604  339  (6,653)
    Changes In Inventories(1,366) -   -   -  
    Changes In Other Operating Activities(18)1,228  (3,526)257  
    Total Cash Flow From Operating Activities 12,583   (16,016) (20,316) 126,607  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(253)(196)(162)(349)
    Investments(22,275)20,817  (80,566)(23,297)
    Other Cash flows from Investing Activities478  310  409  4,456  
    Total Cash Flows From Investing Activities (22,050) 20,931   (80,319) (19,190)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock6,413  255  672  1,483  
    Net Borrowings -   -   -   -  
    Other Cash Flows from Financing Activities -   -   -   -  
    Total Cash Flows From Financing Activities 6,363   255   672   1,263  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents (3,104) 5,170   (99,963) 108,680  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.